SEC Form 4 · accession 0001140361-15-023269
INTERPACE BIOSCIENCES, INC. · IDXG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen J Sullivan
Director
Period of report
Jun 3, 2015
Accepted (ET)
Jun 4, 2015 · 5:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054102
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 3, 2015 | A | 34,091 | $1.32 | A | 97,828 | D | |
| Common StockF1 | holding | — | — | — | 63,737 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $11.49 | holding | — | — | — | — | Jun 7, 2015 | Common Stock | 7,500 | 7,500 | D |
Explanation of responses
- F1Includes 1,859 restricted stock units which vest on June 5, 2015, 6,675 restricted stock units which vest on June 4, 2016, and 3,319 restricted stock units which vest on June 4, 2017.
- F2On June 3, 2015, the date of the Company's annual meeting of stockholders, Mr. Sullivan was granted 34,091 restricted stock units, of which 11,363 vest on June 3, 2016, 11,364 vest on each of June 3, 2017 and June 3, 2018.
- F3Currently exercisable.